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Abstract 
A pivotal gluconeogenic enzyme in Saccharomyces cerevisuae, fructose-1, 6-bisphosphatase 
(FBPase) was selectively turned over in vacuole via Vid (vacuole import and degradation) 
dependent pathway in response to the fresh glucose after chronic glucose starvation. TCO89, 
a novel and unique component of Tor Complex I (TORCI), was found to physically associate 
with FBPase and significantly affect FBPase degradation via Vid pathway. Further investigation 
indicated that ∆tco89 mutant strongly impaired FBPase’s importing into Vid vesicles and 
Vid24’s association with Vid vesicles. Inactivation of TORCI by rapamycin treatment strongly 
blocked FBPase degradation. Other components of TORCI were also found to physically 
associate with FBPase. The P1S mutation of FBPase, reported to block its degradation, was 
observed to impair the association of FBPase with TORCI components.  These results im-
plicated an important regulatory role of TCO89 and TORCI in this pathway.  
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Introduction 
The fructose-1, 6-bisphosphatase (FBPase), a key 
enzyme of gluconeogenic pathway, is rapidly inacti-
vated and selectively turned over when ample glu-
cose is supplied after glucose starvation [1–3]. The 
catabolite degradation of FBPase effectively prevents 
the energy futile cycle between glycolysis and gluco-
neogenesis [1- 4]. Depending on the culture condi-
tions, there are two pathways for FBPase degradation: 
proteasome-dependent degradation and vacuole im-
port and degradation (Vid) dependent pathway [3- 6]. 
It is reported that in one day starvation, FBPase was 
conjugated with multi-ubiquitin chain at Lys 48 dur-
ing its degradation; the 26S proteasome mutant 
cim3-1blocked FBPase degradation at non-permissive 
temperature [4-6]. In two-day or longer starvation 
condition, FPBase is degraded in vacuole, the homo-
logue of lysosome of mammals [1,5]. 
The FBPase degradation via Vid pathway is one 
of an autophagic process in which long-lived proteins 
or cell organelles are engulfed in the membrane or-
ganelles and then targeted to vacuole for degradation 
[2, 7]. Multiple proteins are involved in Vid pathway 
of FBPase degradation: this pathway shares compo-
nents with endocytotic pathway such as V-ATPase 
complex and epsilon cop coatomer complex1 (COPI) 
subunits [8-9]. When mutated in Stv1 or Vph1, the 
subunit of V-ATPase complex, FBPase degradation 
was blocked [8]. When mutated in Sec28, the subunit 
of COPI, FBPase’s association with Vid vesicles and its 
degradation were impaired [9]. This pathway also Int. J. Biol. Sci. 2010, 6 
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required a unique protein Vid24, the protein marker 
of Vid vesicle, which functions in targeting FBPase 
containing vesicles to the vacuole [10]. 
Target of rapamycin (Tor), a conserved phos-
phatidylinositol 3-related protein kinase, plays pivot-
al roles in cell growth and cell metabolism [11-13]. As 
a nutrition sensor, Tor proteins are highly conserved 
from yeast to mammals. In yeast, two Tor proteins 
form two functional distinct protein complexes: Tor 
Complex I (TORC1) and Tor Complex II (TORCII). 
TORCI contains unique components (Tor1 and 
TCO89) and shares components (Tor2, Lst8 and Kog1) 
with TORCII [14-15]. Each component of TORC1 
plays distinct but related functions [16-18]. TORCI 
regulates protein synthesis, ribosome biogenesis, 
transcription and autophagy in response to the nutri-
tion availability and energy status of cells, which are 
sensitive to rapamycin treatment [19-22].  
To further investigate the mechanisms of Vid 
pathway, experiments have been performed to screen 
the yeast deletion library and GST fusion library [23]. 
It has been identified a list of proteins that interact 
with and regulate FBPase degradation in this path-
way. This study reported the role of TCO89, the sub-
u n i t  o f  T O R C I ,  a s  a  n e w  c o m p o n e n t  i n  F B P a s e  d e -
gradation of Vid pathway. TCO89 was found to asso-
ciate with FBPase and regulate FBPase degradation. 
The results showed that all other TORCI components 
associated with FBPase. Thus, this study also impli-
cated a possible role for TORC1 in this pathway. 
Results and Discussion 
TCO89 is required for FBPase degradation in Vid depen-
dent pathway. 
A list of potential FBPase interacting proteins 
were identified through HIS beads pull down assay 
and the MALDI Mass Spectra in the preliminary ex-
periments. Among them, TCO89 was identified as one 
of the FBPase binding proteins. Besides, when 
screening the yeast deletion library, TCO89 was iden-
tified as a potential component of FBPase degradation 
pathway. It is reported that FBPase can be degraded 
via either Vid-dependent pathway or ubiqui-
tin-proteasome pathway depending on the starvation 
conditions [3-6]. In this study, two types of FBPase 
degradations were induced (Fig 1A, 1B). In two-day 
starvation, Vid-dependent degradation was induced; 
most of FBPase (90%) kept intact in Δtco89 mutant (Fig 
1A); while there was only less than 5% of FBPase left 
in wild type strain. Similar to the wild type, mutant 
Δbit61 (one of unique components of Tor Complex II) 
did not affect FBPase degradations in Vid -dependent 
pathway (Fig 1A). However, in one-day starvation, 
ubiquitin-proteasome degradation was induced; as in 
wild type strain and Δbit61 mutant, little FBPase (15%) 
was left in the Δtco89 mutant, (Fig1B).  Based on Fig-
ure 1, loss function of TCO89 exhibited great different 
effect on two FBPase degradation pathways, strong 
suggesting TCO89 played a more exclusive role in 
Vid-dependent pathway for FBPase degradation.  
TCO89 is required for the FBPase import into Vid-vesicles. 
FBPase degradation via Vid pathway can be 
further divided into sequential events: inactivation of 
FBPase, importing of FBPase to Vid vesicles, docket-
ing of FBPase vesicles to vacuole for degradation [27, 
28]. To further investigate the role of TCO89 in this 
pathway, several experiments were performed. We 
first checked the localization of FBPase by differential 
centrifugation (Fig1C). In 30 min FBPase degradation, 
it was found in wild type strain that 1/3 FBPase was 
targeted into vesicles (P) and 2/3 of FBPase was still 
left in cytosol (S); while it was found in Δtco89 mutant 
strain that only less than 1/10 FBPase was targeted 
into vesicles (P) and most of FBPase (9/10) was still 
left in cytosol (S). The results suggested that FBPase 
was severe blocked in the cytosol (S) and was unable 
to target into vesicles (P) properly due to loss function 
of TCO89 (Fig1C).The localization of specific molecu-
lar marker of Vid vesicles--Vid24-- was examined by 
differential centrifugation as well. Interestingly, Vid24 
was found to exclusively reside in the cytosol (S) in 
the  Δtco89 mutant (Fig1C); while as reported, the 
Vid24 resided mostly in the vesicles (P) in wild type 
strain (Fig1C) [10, 29]. Moreover, comparing to the 
wild type strain, Vid24 expression level wasn’t im-
paired much in the Δtco89 mutant. Since FBPase was 
accumulated in the Vid vesicles and could not target 
to vacuole for degradation in Δvid24 mutant [10, 29], 
our results suggested that TCO89 most likely regu-
lated Vid24 localization. In further examining the ac-
tivity of FBPase, FBPase wasn’t found any change in 
its enzyme activity at both starvation condition and 
degradation condition in the Δtco89 mutant compar-
ing to wild type control (S1), so TCO89 did not affect 
FBPase activity in either situations.  
Above all, it seems that TCO89 may  mediate 
FBPase import and also regulate Vid24 association 
with Vid vesicles, and thus control the formation of 
FBPase-containing vesicles [29]. 
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Fig. 1 Regulation of FBPase degradation by TCO89. All strains were glucose starved for indicated time (1day or 2 
days). In the experiments, cell cultures were equally divided and two treatments were given as indicated. Same amount of 
total protein was loaded in the gel for every sample. A. Deletion of TCO89 in Vid-dependent FBPase degradation pathway. 
IB, Immuno-blotting; WT, w303; ∆tco89 and ∆bit61, deletion mutants. B. Deletion of TCO89 in proteasome-dependent 
FBPase degradation. C. The importation of FBPase into Vid vesicle in ∆tco89 mutant. Pellet fraction (P) containing Vid 
vesicles while supernatant fraction (S) containing soluble proteins. D. GST pull-down assay showed the physical association 
of TCO89 with FBPase. IP, immuno-precipitation. E. Sucrose gradient analysis showed co-localization of TCO89, FBPase 
and Vid24 during FBPase degradation.  
 Int. J. Biol. Sci. 2010, 6 
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TCO89 associated with FBPase during starvation and 
degradation  
To investigate the mechanism of TCO89 in re-
gulating FBPase degradation, GST pull-down was 
performed at different conditions (starvation condi-
tion, degradation condition). FBPase was found to 
bind to TCO89 at both starvation and degradation 
conditions, but with less binding affinity at the de-
gradation condition; as a control, UBC8 interacted 
with FBPase (Fig 1D) as reported [30]. The results 
suggested that TCO89 associated with FBPase during 
degradation, but it seems to associate with FBPase at 
the initial steps of the degradation, later it may release 
FBPase into Vesicle or vacuole so less TCO89 binding 
was found in the degradation condition. To further 
investigate if the localizations of TCO89, FBPase and 
Vid24 were in the Vid vesicle, sucrose gradient anal-
ysis was performed. The sucrose gradient fraction 
showed TCO89 overlapped with four fractions of 
FBPase and three fractions of Vid24 during FBPase 
degradation in distribution (Fig 1E). As reported [10], 
FBPase also overlapped with Vid24 very well during 
FBPase degradation in distribution (Fig 1E). These 
results suggested that TCO89 partially interacted with 
FBPase in the Vid vesicle fraction in the degradation 
(Fig1D, 1E), thus it is possible that TCO89 regulated 
vesicle importation of FBPase through protein-protein 
interaction. 
TOR Complex 1(TORCI) played a role in FBPase degra-
dation 
Although TCO89 is a component of TOR Com-
plex 1[15], it is not known if TORC1 functions in Vid 
degradation pathway of FBPase. It is reported that 
TORC1’s function is sensitive to rapamycin, the inhi-
bitor of TOR kinases [15]. Comparing to control 
group, rapamycin treatment blocked FBPase degra-
dation in wild type (Fig. 2A). So the function of 
TORCI is critical for Vid degradation of FBPase. In 
confirming TORC1’s role in FBPase degradation, we 
over-expressed TOR1 and found it caused seriously 
blockage of FBPase degradation (Fig 2B). However, 
the rapamycin treatment did not reverse the defect of 
FBPase degradation in TOR1overexpressing cells (Fig 
2C), which suggested that the impairment of FBPase 
degradation in TOR1 over-expressing cells was not 
due to enhanced TOR1 kinase activity. In Drosophila, 
there is only one TOR protein, but it forms two TOR 
complexes [35-36]. It was reported that 
over-expression of dTOR in wing showed phenotypes 
remarkably similar to the loss of dTOR function mu-
tant, such as decreased cell size and cell-proliferation 
rate, as well as arrested cell cycle in the G1 phase 
during development [37]. Since the N-terminal half of 
the TOR protein is comprised of a series of repeated 
HEAT motifs, alpha-helical domains which mediate 
protein–protein interactions [38], it was thus pro-
posed that abnormally high levels of dTOR can re-
duce dTOR signaling output by binding and titrating 
away factors essential for normal TOR function [37]. 
Recently, it was reported again that over-expression 
of dTOR can hypo- activate TORC1 activity and result 
in small eye Drosophila [39].  It is known that main-
taining of a proper molecular ratio of components in a 
complex is critical to the function of the complex and 
disturbance of the complex organization by 
over-expression of one component may cause domi-
nant negative effect [40]. In the preliminary experi-
ments, we found that FBPase couldn’t be phosphory-
lated in the TOR1 over-expressing cells, suggesting 
that TORCI kinase activity was impaired in the cells. 
It is possible that TOR1 ectopic expression disturbed 
the stoichiometry of TORCI components and im-
paired the function of TORC1 so may cause the do-
minant-negative effect on FBPase degradation.  
It is reported that TOR1 and TOR2 proteins share 
some similar functions and the TOR2 can complement 
the function of TOR1 in vivo [14, 31], so it is not sur-
prising to find that loss function of TOR1 did not af-
fect FBPase degradation (Fig. 2B). However, loss 
function of the unique components of TOR Complex 
I I ,  s u c h  a s  B i t 6 1 ,  A v o 2  o r  A v o 3  d i d  n o t  a f f e c t  t h e  
FBPase degradation in this study (Fig. 2B).Therefore, 
our results strongly implicated a possible role of 
TORCI, not TORCII in Vid-dependent pathway for 
FBPase degradation. 
Similar to TCO89, other components of TORCI physically 
associated with FBPase 
Though the MALDI mass spectra results have 
suggested the components of Tor Complex I asso-
ciated with FBPase, immune-precipitation was also 
performed to confirm if TORC1 associated with 
FBPase. Consistent with TCO89, TOR1, TOR2, Kog1 
and Lst8 all were found to interact with FBPase in the 
starvation status, and also interact with FBPase in 
degradation condition with lower affinity (Fig3A). 
However, the unique components of Tor Complex II, 
Bit61, Avo2 and Avo3 did not interact with FBPase in 
this study (S2).  
To further confirm the interaction of TORC1 
with FBPase, HIS pull-down assay was performed. 
Similar results were found that TOR1, TOR2, Kog1 
and Lst8 associated with FBPase in both starvation 
status and degradation status (Fig 3B). The sucrose 
gradient results also showed Kog1 and Lst8 
co-localized with FBPase in Vid fractions: seven frac-
tions of Kog1 and five fractions of Lst8 respectively Int. J. Biol. Sci. 2010, 6 
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overlapped with FBPase in distribution during 
FBPase degradation (S3), while Vid24 was localized 
with Kog1 and Lst8 at the vesicle fraction respectively 
(S3). The previous study reported that TORCI was 
found in the membrane fractions and also may locate 
in vesicles membranes [24, 32]. So, it is likely that 
TORCI regulates FBPase degradation via its associa-
tion with FBPase, and it seems that the components of 
TORCI gradually dissociated from FBPase during the 
degradation process. We proved that all components 
of TOCR1 physically associated with FBPase by three 
independent methods: sucrose gradient experiment, 
His Pull-down and immuno-precipitation. We will 
further test which component(s) of TORC1 binds to 
FBPase directly. 
 
 
Fig. 2 The involvement of TORC1 in FBPase degradation. All strains were glucose starved for two days. In 
the experiments, the 2ml cell cultures were equally divided and different treatments were given as indicated. Same amount 
of total protein was loaded in the gel for every sample. A. FBPase degradation was rapamycin sensitive. Two-day starved 
cells (-) and starved cells supplied with glucose for 2hrs (+) were treated with ethanol or rapamycin (20nM) during FBPase 
degradation. B. Tor1 overexpression blocked FBPase degradation. WT: w303; Tor1 overexpression: ectopic expression of 
Tor1-V5; Δtor1, Δbit61, Δavo2, and Δavo3: deletion mutants for components of Tor Complex I and Tor complex II. C. 
Rapamycin did not relieve the impairment of FBPase degradation by Tor1 overexpression. Int. J. Biol. Sci. 2010, 6 
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Fig 3 FBPase interacted with components of Tor Complex I. All strains were glucose starved for two days. 
In the experiment, the cell cultures were equally divided and different treatments were given as indicated. Immunopreci-
pitation and pull-down assay were performed as described in the material and methods. Equal total protein was used in the Int. J. Biol. Sci. 2010, 6 
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different treatment. A. FBPase associated with TOR Complex 1 components by immuno-precipitation. Proteins were 
precipitated with rabbit anti-FBPase antibody and protein A bead. The interaction proteins were blotted with HA antibody. 
Starved cells (-) and starved cells supplied with glucose for 30min (+) were used. U, unbound protein, B, bound protein. B. 
FBPase associated with TOR Complex 1 components by HIS pull-down assay. C.P1S FBPase mutant weakly interacted with 
TORCI in HIS pull-down. Immuno-blotting was with mouse anti-HA antibody. 
 
It was reported that an N-terminal mutation of 
FBPase (p1s fbpase) blocked FBPase degradation [5]. In 
this study, this mutation was also found to severely 
weaken the association of FBPase with TOR1, TOR2, 
Kog1 and Lst8 respectively comparing to the wild 
type FBPase (Fig 3B &3C), therefore suggesting that 
TORC1’s association with FBPase is required for 
FBPase degradation.  As reported, FBPase can be 
phosphorylated by cAMP dependent pathway prior 
to its degradation and cAMP pathway cross-talked 
with TORC1 pathway in regulating autophagy [5, 
33-34]. We found that loss of function of TORCI also 
decreased the phosphorylation level of FBPase and 
thus failed to inactivate FBPase activity in response to 
glucose (preliminary data not shown). Therefore, with 
the Thr /Ser protein kinase activity, TORC1 most 
likely regulates FBPase degradation via phosphoryla-
tion as it regulates other proteins. In summary, 
FBPase degradation was analyzed in the mutants of 
Tor Complex I. The results suggested that TCO89 was 
essential for FBPase to be degraded properly in Vid 
dependent pathway —TCO89 was  especially re-
quired for FBPase to be targeted to the Vid vesicles 
through protein-protein interaction. Besides, the 
function of TORCI was required for this pathway as 
well.    
Material and methods 
Yeast strains 
Yeast strains used in this study are listed in   
Table 1.  
Table 1 yeast strains in this study 
Strain                   Genotype 
W303  MATa leu2,3–112 ade2 his3-Δ200 trp1–1 ura3–52 
HLY650  MATαhisΔ1 leu2Δ0 lys2Δ0 ura3Δ0 
BY4742  MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0  (Euroscarf, Germany) 
Δtco89  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 tco89::kanmx4 (Euroscarf, Germany) 
Δarp8  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 arp8::kanmx4 (Euroscarf, Germany) 
Δbit61  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 bit61::kanmx4 (Euroscarf, Germany) 
Δavo2  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 avo2::kanmx4 (Euroscarf, Germany) 
Δavo3  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 avo3::kanmx4 (Euroscarf, Germany) 
Δtor1  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 tor1::kanmx4 (Euroscarf, Germany) 
GST-TCO89  Matα his3-Δ200,leu2-3, 112, ura3-52, pep4::URA, GST-TCO89::LEU [23] 
GST-ARP8         Matα his3-Δ200,leu2-3,112, ura3-52,pep4::URA, GST-ARP8::LEU [23] 
Tor1-V5-HIS  Matα his3-Δ200 ura3-52 leu2, 3-112 trp1-1, Tor1 -V5-HIS URA( this study) 
FBPase -V5-HIS  Mata his3-Δ200 ura3-52 leu2,3-112 trp1-1, FBPase -V5-HIS URA( this study) 
PLY298  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+3HA-TOR1: His3MX6 [22] 
PLY122  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ 3HA-TOR2: His3MX6 [22] 
PLY307  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ LST8-HA:TRP1 [22] 
PLY306  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ KOG1-HA: TRP1 [22] 
PLY336  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+TCO89-MYC:TRP1 [22] 
HLY2100  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+3HA- TOR1: His3MX6, FBPase -V5-HIS LEU( this study) 
HLY2101  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ 3HA-TOR2:His3MX6, FBPase -V5-HIS LEU( this study) 
HLY2102  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ LST8-HA: TRP1 FBPase -V5-HIS LEU( this study) 
HLY2103  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ KOG1-HA: TRP1 FBPase -V5-HIS LEU( this study) 
HLY2104  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ 3HA-TOR1:His3MX6, P1S fbpase -V5-HIS LEU( this study) 
HLY2105  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ 3HA-TOR2:His3MX6, P1S fbpase -V5-HIS LEU( this study) 
HLY2106  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ LST8-HA: TRP1, P1S fbpase -V5-HIS LEU( this study) 
HLY2107  MATa ade2-1 trp1-1 can1-100 leu2-3 112 his3-11, 15 ura3 GAL+ KOG1-HA: TRP1, P1S fbpase -V5-HIS LEU( this study) 
 
Yeast starvation and rapamycin treatment 
Yeast cells (1:250 ratios) were inoculated in 
YPKG (1% yeast extract, 2% peptone,1% 
KCH3COOH, 0.5% dextrose) or YPKGal (1% yeast 
extract, 2% peptone,1% KCH3COOH, 0.5% Galactose) 
medium for either one day or two days to perform 
glucose starvation. To induce FBPase degradation, 
YPKG or YPKGal medium was removed and fresh 
YPD was added for indicated time. Without specific Int. J. Biol. Sci. 2010, 6 
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indication, the yeast starvation was 2 days and FBPase 
degradation was induced for 30 min. For rapamycin 
treatment, yeast cultures were grown in 20nM rapa-
mycin (Sigma) YPD medium, control group was 
treated with YPD containing same amount of ethanol 
[24]. 
Western blotting and antibodies 
Western blotting was performed with standard 
protocol [10]. Primary antibodies included monoc-
lonal mouse anti-HA antibody (1:5000) (Roche), mo-
noclonal mouse anti-V5 antibody (1:5000) (Life Tech-
nologies) and polyclonal rabbit anti-FBPase antibody 
(1:10000) [25]. Secondary antibody included HRP 
conjugated anti-rabbit antibody (1:5,000) and HRP 
conjugated anti-mouse antibody (1:5,000) (Amersham 
Biosciences). 
Differential fractionation 
Differential fractionation was performed as de-
scribed [10]. Cells were lysed with lysis buffer (50 mM 
Hepes-NaOH, pH 7.4, 5  mM MgSO4, 40 mM 
(NH4)2SO4, 0.1mM EDTA, 1mM PMSF). Total soluble 
proteins were subjected to a series of centrifugations. 
The high speed supernatant and pellet were analyzed 
with Western blotting. 
GST pull-down 
Yeast strains containing GST fused with the 
amino-terminus of TCO89 or UBC8 open reading 
frame respectively were used. GST pull-down was 
performed as described [10]. Cells were lysed in GST 
buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, pH 7.4, 1mM PMSF). Total lysates 
were spun down at 13,000g for 20min. The superna-
tants were incubated with equilibrated gluta-
thione-Sepharose 4B  beads (Amersham Biosciences) 
for 2 hours at 4°C. GST beads were collected by spin-
ning down at 500g for 1min after incubation. The in-
cubated GST beads were washed with lysis buffer for 
3 times. And GST bounded proteins were analyzed 
with Western blotting. 
FBPase Immunoprecipitation 
Immunoprecipitation was performed as de-
scribed [10]. 10 ml yeast cells were lysed in IP buffer 
(50 mM Tris, pH 7.4, 200 mM NaCl, 5 mM EDTA, 1 
mM PMSF). Total lysates were spun down at 200,000g 
for 2 hours to enrich vesicle proteins. The pellets were 
suspended and incubated with 1ul of FBPase antibo-
dy to form antigen- antibody complex at 4°C for 2 
hour.  Then equilibrated protein A beads (Amersham 
Biosciences) were added and followed with 1 hour 
rotating at 4°C. FBPase interacting proteins were pre-
cipitated by collecting protein A beads at 500g for 
1min. Incubated Protein A beads were washed for 3 
times. The FBPase interaction proteins were analyzed 
by Western blotting. 
HIS pull-down 
FBPase open reading frame fused with V5 and 
HIS tag at the carboxyl-terminus was transformed 
into respective yeast strains. HIS pull-down was per-
formed according to the product manual (Qiagen). 10 
ml yeast cells were lysed in HIS lysis buffer (50 mM 
NaH2PO4, 300 mM NaCl, 10 mM imidazole, 0.05% 
Tween20, pH 8.0, 1mM PMSF and 1x cocktail protei-
nase inhibitors (Roche). Total lysates were spun down 
at 200,000g for 2 hours at 4°C. Pellets were resus-
pended and incubated with equilibrated Ni-NTA 
agarose for 2-3 hours at 4°C. Incubated Ni-NTA aga-
rose was collected and washed 3 times with 10x vo-
lume of washing buffer (50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole, 0.05% Tween 20, pH 8.0, 
1mM PMSF). Elution buffer (50 mM NaH2PO4, 300 
mM NaCl, 250 mM imidazole, 0.05% Tween20, pH8.0, 
1mM PMSF) was added and incubated for 5min at 
4°C. Elute was collected for Western blotting analysis. 
Sucrose-gradient 
Sucrose gradient was performed as described 
[26]. 10 ml of cell were starved from glucose for 2 
days. Total cell lysates were subjected to differential 
fractionation. High-speed pellets (100,000x g) were 
loaded to the top of sucrose gradient and were cen-
trifuged at 100,000g for 14-16 hours at 4°C.  Protein 
samples from gradients were fractionated into 1mls. 
And the 1ml protein sample fractions were precipi-
tated with 10% of TCA. The precipitations of the pro-
teins samples were washed and suspended with SDS 
loading buffer. All protein fraction samples were 
subjected to Western blotting analysis. 
Determination of protein concentration 
Protein concentration in different yeast extracts 
were determined by the Bradford method using BSA 
as the protein standard [41]. 
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Figures 
 
Fig. S1: Loss function of TCO89 did not affect FBPase activity in enzyme activity assay. Yeast strains were starved as 
described. Samples of no glucose added (-) and glucose added for 15 min and 30 min (+) were subjected to enzyme activity 
assay as reported [1].   
 
Fig. S2: GST pull-down showed that unique components of Tor complex 2 did not associate with FBPase. 
 
 
Fig. S3: Sucrose gradient showed that Lst8 and Kog1 co-subcellular localized with FBPase and Vid24. 